Choosing the best graft material for glaucoma surgery
Part of Eyes & vision clinical trials.
This trial compares three types of tissue grafts (sclera, pericardium, and cornea) used during certain glaucoma surgeries. It aims to find which graft works best to help control eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years old or older
- Already scheduled for a PreserFlo microshunt or XEN stent surgery, possibly with cataract surgery
- Able to understand the study procedures
- Willing and able to give consent and attend follow-up visits
- Not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
This trial tests two small drainage devices (PreserFlo and XEN stents) for glaucoma, sometimes with an amniotic membrane. The goal is to see which approach is safer and more effective at lowering eye pressure.
This trial tests a tiny implant called Preserflo to treat glaucoma (high eye pressure) that hasn't been controlled with eyedrops. The surgery aims to lower pressure safely while avoiding complications like pressure that drops too low.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
This study compares two surgical drainage devices used for glaucoma and looks at how they affect the clear front window of the eye (the cornea). It may help you understand which device is gentler on the cornea over time.
This trial compares two types of glaucoma drainage devices (Baerveldt and Paul) in people whose glaucoma is not well controlled with eye drops. It aims to find which device works better at lowering eye pressure and is safer.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.